GlassScriptPhysician profile
Colleen C Gaffney
NPI 1295957579
$475.93
in general payments reported to CMS, 2019-2025
15 companies · $212 in 2025
The $212 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $140 · 2024: $124 · 2025: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $336.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $335.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $125.00 | 2022 | |
| Csl Behring | $49.14 | 2024-2025 | Hizentra, Kcentra |
| Ucb, INC. | $33.06 | 2025 | Rystiggo |
| Neurocrine Biosciences, INC. | $31.56 | 2025 | |
| Jazz Pharmaceuticals INC. | $31.34 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $27.23 | 2025 | Hyqvia |
| Alexion Pharmaceuticals, INC. | $26.27 | 2025 | Ultomiris |
| Axsome Therapeutics, INC. | $24.96 | 2025 | Symbravo |
| Emd Serono, INC. | $23.97 | 2025 | |
| Supreme Orthopedic Systems, LLC | $21.04 | 2024 | |
| Lilly USA, LLC | $18.84 | 2024 | Emgality, Reyvow |
| Lundbeck LLC | $17.28 | 2025 | Vyepti |
| Arcutis Biotherapeutics, INC. | $15.63 | 2024 | Zoryve |
| Abbvie INC. | $15.59 | 2024 | |
| Avanos Medical | $15.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colleen Gaffney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.